Schedule 13D ownership disclosure
AUTOLUS THERAPEUTICS LTD
Security class unavailable · CUSIP: 05280R100
Event date: 2024-05-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-143963
- Form type
- SC 13D
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- May 21, 2024
- Reporting period
- May 17, 2024
- Description
- Schedule 13D beneficial ownership